Form 4: Vertex Pharmaceuticals EVP Charles Wagner Jr. Reports Stock Disposal
SEC Form 4 Filing
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals, disposed of 3,310 shares of common stock on February 24, 2025, to cover tax obligations.
Summary
- On February 24, 2025, Charles F. Wagner Jr., the EVP & Chief Financial Officer of Vertex Pharmaceuticals, disposed of 3,310 shares of common stock.
- The transaction was executed at a price of $483.28 per share.
- Following the transaction, Wagner directly owns 59,931 shares of Vertex Pharmaceuticals common stock.
- The transaction was reported on February 26, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a stock disposal, likely for tax purposes, which is a routine transaction.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like Charles Wagner, transact in their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- The transaction itself is unlikely to have a significant impact on stakeholders, as it is a relatively small number of shares being disposed of by an individual executive.
Key Dates
| Date | Description |
|---|---|
| 02/24/2025 | Date of stock disposal transaction |
| 02/26/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.